nNOS-expressing neurons in the vmPFC transform pPVT-derived chronic pain signals into anxiety behaviors

Nat Commun. 2020 May 19;11(1):2501. doi: 10.1038/s41467-020-16198-5.

Abstract

Anxiety is common in patients suffering from chronic pain. Here, we report anxiety-like behaviors in mouse models of chronic pain and reveal that nNOS-expressing neurons in ventromedial prefrontal cortex (vmPFC) are essential for pain-induced anxiety but not algesia, using optogenetic and chemogenetic strategies. Additionally, we determined that excitatory projections from the posterior subregion of paraventricular thalamic nucleus (pPVT) provide a neuronal input that drives the activation of vmPFC nNOS-expressing neurons in our chronic pain models. Our results suggest that the pain signal becomes an anxiety signal after activation of vmPFC nNOS-expressing neurons, which causes subsequent release of nitric oxide (NO). Finally, we show that the downstream molecular mechanisms of NO likely involve enhanced glutamate transmission in vmPFC CaMKIIα-expressing neurons through S-nitrosylation-induced AMPAR trafficking. Overall, our data suggest that pPVT excitatory neurons drive chronic pain-induced anxiety through activation of vmPFC nNOS-expressing neurons, resulting in NO-mediated AMPAR trafficking in vmPFC pyramidal neurons.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Anxiety
  • Behavior, Animal
  • Chronic Pain / enzymology*
  • Chronic Pain / genetics
  • Chronic Pain / psychology*
  • Humans
  • Male
  • Mice
  • Mice, Inbred C57BL
  • Midline Thalamic Nuclei / cytology
  • Midline Thalamic Nuclei / enzymology*
  • Neurons / cytology
  • Neurons / enzymology*
  • Nitric Oxide / metabolism
  • Nitric Oxide Synthase Type I / genetics
  • Nitric Oxide Synthase Type I / metabolism*
  • Prefrontal Cortex / cytology
  • Prefrontal Cortex / enzymology*

Substances

  • Nitric Oxide
  • Nitric Oxide Synthase Type I
  • Nos1 protein, mouse